Ratings Surperformance

Trader
Investor
Global
Quality
-
ESG MSCI
-

Ratings ESG MSCI

Ratings HBM Healthcare Investments AG: Strengths and Weaknesses

  • According to MSCI, the company's ESG score for its industry is poor.
Highlights: HBM Healthcare Investments AG
  • The company's share price in relation to its net book value makes it look relatively cheap.
  • The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
Weaknesses: HBM Healthcare Investments AG
  • The company's earnings growth outlook lacks momentum and is a weakness.
  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 187.7 times its estimated earnings per share for the ongoing year.
  • Based on current prices, the company has particularly high valuation levels.
  • The valuation of the company is particularly high given the cash flows generated by its activity.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • The average consensus view of analysts covering the stock has deteriorated over the past four months.
  • Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Rating Financials

HBM Healthcare Investments AG SectorSwitzerland

Fundamentals

-

Growth

Revenue growth

EPS growth

FCF growth

Profitability

EBITDA Margin

EBIT Margin

Net Margin

Capital Efficiency

-

ROA

-

ROCE

-

ROE

-

Financial Health

-

Gearing

-

Leverage

Capital Intensity

-

Balance sheet growth

-

Long Term balance sheet growth

-

Long term revenue growth

-

Long term EPS growth

More ratings

Rating Valuation

HBM Healthcare Investments AG SectorSwitzerland

Global Valuation

Enterprise value

EV/Revenue

EV/EBITDA

EV/FCF

Equity Valuation

P/E

PBR

Dividend Yield

EV/EBIT

CAPEX/Revenue

-
More ratings

Rating Consensus

HBM Healthcare Investments AG SectorSwitzerland

Consensus

Analysts' buy/sell recommendations

Analysts' recommendations evolution (1 year)

Analysts' recommendations evolution (4 months)

Analysts' target price

Analysts' target price evolution (1 year)

Analysts' target price evolution (4 months)

Analysts' recommendations evolution (7 days)

Target Price evolution (7 days)

More ratings

Rating Business Predictability

HBM Healthcare Investments AG SectorSwitzerland

Visibility

Analysts' coverage

Financial estimates divergence

Analysts' recommendations divergence

Analysts' Target price divergence

-

Surprise rates

Rating Revisions

HBM Healthcare Investments AG SectorSwitzerland

Financial revisions

Revenue revisions (1 year)

Revenue revisions (4 months)

EPS revisions (1 year)

EPS revisions (4 months)

EPS revisions (7 days)

Revenue revisions (7 days)

More ratings

Capi.($) Investor ESG MSCI Fundamentals Financial revisions Global Valuation Visibility Consensus
1.93B - -
2.77B -
B
- -
1.18B
AA
1.07B - - - - - - -
693M - - - - - - -
454M - - - - - - -
377M - - - - - - -
377M - - - - - - -
374M - - - - - - -
370M - - - - - - -
Average 959.64M
BBB
Weighted average by Cap.
BBB
  1. Stock Market
  2. Equities
  3. HBMN Stock
  4. Ratings HBM Healthcare Investments AG